Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Pharming Group N.V.

9.75
-0.2000-2.01%
Post-market: 10.000.2546+2.61%19:30 EDT
Volume:12.41K
Turnover:121.96K
Market Cap:688.60M
PE:77.04
High:9.96
Open:9.95
Low:9.75
Close:9.95
52wk High:21.34
52wk Low:9.62
Shares:70.63M
Float Shares:69.50M
Volume Ratio:0.32
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1266
EPS(LYR):0.0400
ROE:3.65%
ROA:3.47%
PB:2.55
PE(LYR):243.75

Loading ...

OverviewCompanyNewsFilings

Sector Update: Healthcare Stocks Advance Pre-Bell Tuesday

MT Newswires Live
·
Sep 29

Pharming CEO Fabrice Chouraqui Resigns After Disagreement on Direction

Dow Jones
·
Sep 29

Pharming Appoints Leverne Marsh, Kenneth Lynard as Co-CEOs

MT Newswires Live
·
Sep 29

Press Release: Pharming Announces CEO Transition

Dow Jones
·
Sep 29

Top Midday Stories: Akamai's $11.6 Billion Anthropic Deal; Scholastic Q1 Loss Widens; Nektar Awarded $90 Million in Eli Lilly Case

MT Newswires Live
·
Sep 26

Pharming Says FDA Accepts sNDA for Lower-Dose Joenja in Children With APDS

MT Newswires Live
·
Sep 25

Pharming announces FDA acceptance, Priority review of sNDA for Joenja

TIPRANKS
·
Sep 25

Canaccord Genuity Reaffirms Their Buy Rating on Pharming Group (PHAR)

TIPRANKS
·
Sep 23

Pharming Group Price Target Maintained with a $37.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 23

Pharming’s initial Phase 2 Leniolisib data ‘encouraging,’ says H.C. Wainwright

TIPRANKS
·
Sep 22

Pharming Group Price Target Maintained with a $37.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 14

Pharming Gets FDA Approval for Joenja to Treat APDS in Children Aged 4-11

MT Newswires Live
·
Sep 12

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

Pharming Launches Joenja in Japan for Adult, Pediatric APDS Patients

MT Newswires Live
·
Aug 13

Pharming Group is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Aug 04

Analysts Conflicted on These Healthcare Names: Bausch + Lomb Corporation (BLCO) and Pharming Group (PHAR)

TIPRANKS
·
Jul 31

Pharming Group's Q2 Earnings, Revenue Fall; 2026 Revenue Outlook Updated

MT Newswires Live
·
Jul 30

Pharming Group NV Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Pharming Q2 EPS $0.02, Inline, Sales $90.200M Miss $100.625M Estimate

Benzinga Earnings
·
Jul 30

Press Release: Pharming Reports Second Quarter and First Half 2026 Financial Results and Revises Year-end Guidance; Strong Joenja Momentum and Near-term Clinical Readouts to Support Broader Therapeutic Use

Dow Jones
·
Jul 30
More